Apolipoprotein A-IV reduced metabolic inflammation in white adipose tissue by inhibiting IKK and JNK signaling in adipocytes

Mol Cell Endocrinol. 2023 Jan 1:559:111813. doi: 10.1016/j.mce.2022.111813. Epub 2022 Oct 29.

Abstract

Apolipoprotein A-IV (ApoA-IV) plays a role in satiation and serum lipid transport. In diet-induced obesity (DIO) C57BL/6J mice, ApoA-IV deficiency induced in ApoA-IV-/-knock-out (KO mice) resulted in increased bodyweight, insulin resistance (IR) and plasma free fatty acid (FFA), which was partially reversed by stable ApoA-IV-green fluorescent protein (KO-A4-GFP) transfection in KO mice. DIO KO mice exhibited increased M1 macrophages in epididymal white adipose tissue (eWAT) as well as in the blood. Based on RNA-sequencing analyses, cytokine-cytokine receptor interactions, T cell and B cell receptors, and especially IL-17 and TNF-α, were up-regulated in eWAT of DIO ApoA-IV KO compared with WT mice. Supplemented ApoA-IV suppressed lipopolysaccharide (LPS)-induced IKK and JNK phosphorylation in Raw264.7 macrophage cell culture assays. When the culture medium was supplemented to 3T3-L1 adipocytes they exhibited an increased sensitivity to insulin. ApoA-IV protects against obesity-associated metabolic inflammation mainly through suppression in M1 macrophages of eWAT, IL17-IKK and IL17-JNK activity.

Keywords: ApoA-IV; CD8(+) T lymphocytes; Cytokines; Diet-induced obesity; Metabolic inflammation; Pro-inflammatory macrophages.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes
  • Adipose Tissue, White*
  • Animals
  • Apolipoproteins A*
  • I-kappa B Kinase / metabolism
  • Inflammation
  • MAP Kinase Kinase 4 / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Obesity

Substances

  • apolipoprotein A-IV
  • Apolipoproteins A
  • MAP Kinase Kinase 4
  • I-kappa B Kinase